# Elucidating the potential carcinogenic molecular mechanisms of parabens in head and neck squamous cell carcinoma through network toxicology and molecular docking

**Authors:** Lei Zhao, Jianwang Yang, Tao Liu, Huan Cao, Miaomiao Yu, Baoshan Wang, Amel El Asely, Amel El Asely, Amel El Asely

PMC · DOI: 10.1371/journal.pone.0333867 · PLOS One · 2026-03-23

## TL;DR

This study explores how parabens might cause head and neck cancer by analyzing their molecular effects and interactions with key genes.

## Contribution

The study introduces a novel network toxicology and molecular docking approach to uncover paraben-induced carcinogenic mechanisms in HNSCC.

## Key findings

- Eighty common targets were identified linking parabens to HNSCC, with 12 hub genes involved in cell cycle and p53 signaling.
- CCNA1 was validated as a poor survival prognostic factor in HNSCC and showed strong paraben binding.
- Parabens may hinder immune responses by reducing CD8+ T cell and B cell infiltration in HNSCC.

## Abstract

This study aims to systematically investigate the molecular mechanisms through which parabens may contribute to head and neck squamous cell carcinoma (HNSCC) carcinogenesis using integrated network toxicology and molecular docking.

Six commonly used parabens (ethyl-, propyl-, methyl-, heptyl-, butyl-, and benzylparaben) were selected for toxicity prediction via ProTox 3.0 and ADMETlab2.0. Their potential targets were retrieved from Swiss Target Prediction, ChEMBL, and the Similarity Ensemble Approach (SEA). HNSCC-related targets were collected from GeneCards, OMIM, and CTD, while differentially expressed genes (DEGs) were identified using TCGA-HNSC data. Functional enrichment, protein-protein interaction (PPI) network construction, hub gene identification, molecular docking, and immune infiltration analyses were performed using DAVID, STRING, Cytoscape, CB-DOCK2, and TIMER2.0.

We identified 80 common targets through which parabens may exert toxic effects in HNSCC. Among these, 12 hub genes (CCNB1, CDK1, CCNA2, CDK2, CDK4, TYMS, AURKA, CCNA1, CHEK1, CCNB2, PLK1, CDC25A) were significantly overexpressed in HNSCC tissues and were primarily enriched in cell cycle regulation, p53 signaling, and viral carcinogenesis pathways. CCNA1 was further validated as an independent prognostic factor associated with poor survival. Molecular docking revealed strong binding affinities between parabens and hub proteins. Immune infiltration analysis indicated a negative correlation between CCNA1 expression and CD8 + T cell and B cell infiltration.

Parabens may promote HNSCC progression by disrupting cell cycle regulation and immune responses via direct interactions with key hub genes. These findings provide a novel mechanistic basis for the carcinogenic potential of parabens in HNSCC and underscore the need for further experimental and epidemiological validation.

## Linked entities

- **Genes:** CCNB1 (cyclin B1) [NCBI Gene 891], CDK1 (cyclin dependent kinase 1) [NCBI Gene 983], CCNA2 (cyclin A2) [NCBI Gene 890], CDK2 (cyclin dependent kinase 2) [NCBI Gene 1017], CDK4 (cyclin dependent kinase 4) [NCBI Gene 1019], TYMS (thymidylate synthetase) [NCBI Gene 7298], AURKA (aurora kinase A) [NCBI Gene 6790], CCNA1 (cyclin A1) [NCBI Gene 8900], CHEK1 (checkpoint kinase 1) [NCBI Gene 1111], CCNB2 (cyclin B2) [NCBI Gene 9133], PLK1 (polo like kinase 1) [NCBI Gene 5347], CDC25A (cell division cycle 25A) [NCBI Gene 993]
- **Chemicals:** ethylparaben (PubChem CID 8434), propylparaben (PubChem CID 7175), methylparaben (PubChem CID 7456), heptylparaben (PubChem CID 14138), butylparaben (PubChem CID 7184), benzylparaben (PubChem CID 7180)
- **Diseases:** head and neck squamous cell carcinoma (MONDO:0010150), HNSCC (MONDO:0010150)

## Full-text entities

- **Genes:** CHEK1 (checkpoint kinase 1) [NCBI Gene 1111] {aka CHK1, OZEMA21}, CCNA2 (cyclin A2) [NCBI Gene 890] {aka CCN1, CCNA}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, TYMS (thymidylate synthetase) [NCBI Gene 7298] {aka DKCD, HST422, TMS, TS}, CDK1 (cyclin dependent kinase 1) [NCBI Gene 983] {aka CDC2, CDC28A, P34CDC2}, PI3K [NCBI Gene 107795370], CCNA1 (cyclin A1) [NCBI Gene 8900] {aka CT146}, AURKA (aurora kinase A) [NCBI Gene 6790] {aka AIK, ARK1, AURA, BTAK, PPP1R47, STK15}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, CDK2 (cyclin dependent kinase 2) [NCBI Gene 1017] {aka CDKN2, p33(CDK2)}, ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}, CDC25A (cell division cycle 25A) [NCBI Gene 993] {aka CDC25A2}, DOCK2 (dedicator of cytokinesis 2) [NCBI Gene 1794] {aka IMD40}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, CCNB1 (cyclin B1) [NCBI Gene 891] {aka CCNB}, CCNB2 (cyclin B2) [NCBI Gene 9133] {aka HsT17299}, PLK1 (polo like kinase 1) [NCBI Gene 5347] {aka PLK, STPK13}, EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}, CDK4 (cyclin dependent kinase 4) [NCBI Gene 1019] {aka CMM3, MCPH31, PSK-J3}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}
- **Diseases:** OMIM (MESH:D030342), allergic skin reactions (MESH:D004342), T-cell leukemia virus 1 infection (MESH:D015458), Epstein-Barr virus infection (MESH:D020031), diabetes (MESH:D003920), Head and Neck Squamous Cell Carcinoma (MESH:D000077195), head and neck cancers (MESH:D006258), carcinogenic (MESH:D011230), laryngeal cancer (MESH:D007822), Toxicity (MESH:D064420), breast cancer (MESH:D001943), carcinogenesis (MESH:D063646), obesity (MESH:D009765), Cancer (MESH:D009369), metastasis (MESH:D009362), thyroid diseases (MESH:D013959), viral carcinogenesis (MESH:D014777), reproductive disorders (MESH:D060737)
- **Chemicals:** butylparaben (MESH:C038091), benzylparaben (MESH:C057775), progesterone (MESH:D011374), alcohol (MESH:D000438), Heptylparaben (MESH:C481602), Parabens (MESH:D010226), NAAS (-), hydrogen (MESH:D006859)
- **Species:** Nicotiana tabacum (American tobacco, species) [taxon 4097], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13008085/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13008085/full.md

## References

107 references — full list in the complete paper: https://tomesphere.com/paper/PMC13008085/full.md

---
Source: https://tomesphere.com/paper/PMC13008085